Oxford BioMedica Financial Overview
Oxford BioMedica's market cap is currently $947.00M. The company's EPS TTM is $; its P/E ratio is -17.38; Oxford BioMedica is scheduled to report earnings on September 23, 2025, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.
